|
Volumn 20, Issue 3, 2006, Pages 193-195
|
Spotlight on bevacizumab in advanced colorectal cancer, breast cancer, and non-small cell lung cancer.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
BREAST TUMOR;
CLINICAL TRIAL;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METASTASIS;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
HUMANS;
LUNG NEOPLASMS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 33750631921
PISSN: 11738804
EISSN: None
Source Type: Journal
DOI: 10.2165/00063030-200620030-00007 Document Type: Review |
Times cited : (24)
|
References (27)
|